Timur Dogan - Aug 25, 2023 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Role: Chief Technology Officer
Signature: /s/ Elisa Luqman as attorney-in-fact for Timur Dogan
Stock symbol: CDIO
Transactions as of: Aug 25, 2023
Transactions value $: $9,964
Form type: 4
Date filed: 9/8/2023, 12:12 PM
Previous filing: Jun 27, 2023
Next filing: Feb 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDIO	Common Stock	Purchase	$982	+1.77K	+1.61%	$0.56	112K	Aug 25, 2023	Direct	F1
transaction	CDIO	Common Stock	Purchase	$8.98K	+16.5K	+14.73%	$0.55	128K	Aug 31, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
F2	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.